AXA SA: fresh sell signal in week one, trading not recommended
AXA SA receives a fresh sell signal in week one. Signal strength is low at 21 out of 100. Quality band flags trading not recommended: elevated-risk conditions for new entries per our model.
High signal strength, structure still building: the trade enters active management
CoreWeave is at week 6 of its buy signal with signal strength at 87 out of 100 and the stop moved to breakeven. The first statistical window has already been hit: the trade now enters active management toward the next threshold at week 8.
CrowdStrike: active signal with two targets hit, first management window approaching
CrowdStrike is in week 5 of a BUY with signal strength at 70 out of 100 and two DL2 targets already hit. The stop is at breakeven, risk zeroed out. Week 6 brings the first statistical reduction window.
CRISPR Therapeutics: active sell signal, but weakening
Sell signal at week 4 on CRISPR Therapeutics, with strength down to 36 out of 100. The confirmation week closed bullish: discipline suggests exiting the position. New entries are not recommended by our model.
Salesforce: sell signal under observation, trading not recommended
Salesforce carries a sell signal at week 18 with fading strength at 25 out of 100. The quality band flags trading not recommended: the rebound from lows makes opening new short positions high-risk per our model.
Credo Technology: high signal strength at all-time highs, active management ahead
BUY active at week 5 with signal strength at 87 out of 100 and the setup quality indicator in tension. Price is near all-time highs, 1 week to the first reduction window.